Comprehensive seroprofiling of sixteen B. burgdorferi OspC: Implications for Lyme disease diagnostics design

Clinical Immunology

Volumn 132, Issue 3, 2009, Pages 393-400

  Ivanova, Larisa ^a   Christova, Iva ^a,b   Neves, Vera ^c   Aroso, Miguel ^c   Meirelles, Luciana ^c   Brisson, Dustin ^d   Gomes Solecki, Maria ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^c Biopeptides Corp   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Borrelia; Diagnostics; Lyme; OspC seroprofile

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; EPITOPE; OUTER SURFACE PROTEIN C; OUTER SURFACE PROTEIN C ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BACTERIUM DETECTION; BLOOD SAMPLING; BORRELIA BURGDORFERI; CONTROLLED STUDY; CROSS REACTION; DOG; ERYTHEMA CHRONICUM MIGRANS; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LYME DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SERODIAGNOSIS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CROSS REACTIONS; DOGS; GENOTYPE; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYME DISEASE; MALE; MICE; MICE, INBRED C3H; PEROMYSCUS; RECOMBINANT PROTEINS; SEROLOGIC TESTS;

EID: 67651155750     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.05.017     Document Type: Article

References (43)

1. Bratton R.L., Whiteside J.W., Hovan M.J., Engle R.L., and Edwards F.D. Diagnosis and treatment of Lyme disease. Mayo. Clin. Proc. 83 (2008) 566-571
2. Plorer A., Sepp N., Schmutzhard E., Krabichler S., Trobos S., Schauer G., Pahl C., Stoffler G., and Fritsch P. Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status. J. Invest. Dermatol. 100 (1993) 103-109
3. Smith R.P. Current diagnosis and treatment of lyme disease. Compr. Ther. 31 (2005) 284-290
4. Baranton G., Seinost G., Theodore G., Postic D., and Dykhuizen D. Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity. Res. Microbiol. 152 (2001) 149-156
5. Liang F.T., Steere A.C., Marques A.R., Johnson B.J., Miller J.N., and Philipp M.T. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J. Clin. Microbiol. 37 (1999) 3990-3996
6. Bacon R.M., Biggerstaff B.J., Schriefer M.E., Gilmore Jr. R.D., Philipp M.T., Steere A.C., Wormser G.P., Marques A.R., and Johnson B.J. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis. 187 (2003) 1187-1199
7. Gomes-Solecki M.J., Wormser G.P., Persing D.H., Berger B.W., Glass J.D., Yang X., and Dattwyler R.J. A first-tier rapid assay for the serodiagnosis of Borrelia burgdorferi infection. Arch. Intern. Med. 161 (2001) 2015-2020
8. Nowakowski J., Schwartz I., Liveris D., Wang G., Aguero-Rosenfeld M.E., Girao G., McKenna D., Nadelman R.B., Cavaliere L.F., and Wormser G.P. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin. Infect. Dis. 33 (2001) 2023-2027
9. Bissett M.L., and Hill W. Characterization of Borrelia burgdorferi strains isolated from Ixodes pacificus ticks in California. J. Clin. Microbiol. 25 (1987) 2296-2301
10. Wilske B., Preac-Mursic V., Schierz G., Kuhbeck R., Barbour A.G., and Kramer M. Antigenic variability of Borrelia burgdorferi. Ann. N.Y. Acad. Sci. 539 (1988) 126-143
11. Pal U., Yang X., Chen M., Bockenstedt L.K., Anderson J.F., Flavell R.A., Norgard M.V., and Fikrig E. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J. Clin. Invest. 113 (2004) 220-230
12. Grimm D., Tilly K., Byram R., Stewart P.E., Krum J.G., Bueschel D.M., Schwan T.G., Policastro P.F., Elias A.F., and Rosa P.A. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3142-3147
13. Stewart P.E., Wang X., Bueschel D.M., Clifton D.R., Grimm D., Tilly K., Carroll J.A., Weis J.J., and Rosa P.A. Delineating the requirement for the Borrelia burgdorferi virulence factor OspC in the mammalian host. Infect. Immun. 74 (2006) 3547-3553
14. Tilly K., Krum J.G., Bestor A., Jewett M.W., Grimm D., Bueschel D., Byram R., Dorward D., Vanraden M.J., Stewart P., and Rosa P. Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect. Immun. 74 (2006) 3554-3564
15. Stevenson B., Schwan T.G., and Rosa P.A. Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 63 (1995) 4535-4539
16. Wilske B., Preac-Mursic V., Jauris S., Hofmann A., Pradel I., Soutschek E., Schwab E., Will G., and Wanner G. Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect. Immun. 61 (1993) 2182-2191
17. Theisen M., Frederiksen B., Lebech A.M., Vuust J., and Hansen K. Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen. J. Clin. Microbiol. 31 (1993) 2570-2576
18. Padula S.J., Dias F., Sampieri A., Craven R.B., and Ryan R.W. Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 32 (1994) 1733-1738
19. Fung B.P., McHugh G.L., Leong J.M., and Steere A.C. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Infect. Immun. 62 (1994) 3213-3221
20. Gerber M.A., Shapiro E.D., Bell G.L., Sampieri A., and Padula S.J. Recombinant outer surface protein C ELISA for the diagnosis of early Lyme disease. J. Infect. Dis. 171 (1995) 724-727
21. Mathiesen M.J., Christiansen M., Hansen K., Holm A., Asbrink E., and Theisen M. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J. Clin. Microbiol. 36 (1998) 3474-3479
22. Panelius J., Lahdenne P., Heikkila T., Peltomaa M., Oksi J., and Seppala I. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis. J. Med. Microbiol. 51 (2002) 731-739
23. Jobe D.A., Lovrich S.D., Asp K.E., Mathiason M.A., Albrecht S.E., Schell R.F., and Callister S.M. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC. Clin. Vaccine Immunol. 15 (2008) 981-985
24. Balmelli T., and Piffaretti J.C. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res. Microbiol. 146 (1995) 329-340
25. Wormser G.P., Liveris D., Nowakowski J., Nadelman R.B., Cavaliere L.F., McKenna D., Holmgren D., and Schwartz I. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J. Infect. Dis. 180 (1999) 720-725
26. Seinost G., Dykhuizen D.E., Dattwyler R.J., Golde W.T., Dunn J.J., Wang I.N., Wormser G.P., Schriefer M.E., and Luft B.J. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect. Immun. 67 (1999) 3518-3524
27. Ruzic-Sabljic E., Arnez M., Lotric-Furlan S., Maraspin V., Cimperman J., and Strle F. Genotypic and phenotypic characterisation of Borrelia burgdorferi sensu lato strains isolated from human blood. J. Med. Microbiol. 50 (2001) 896-901
28. Ojaimi C., Mulay V., Liveris D., Iyer R., and Schwartz I. Comparative transcriptional profiling of Borrelia burgdorferi clinical isolates differing in capacities for hematogenous dissemination. Infect. Immun. 73 (2005) 6791-6802
29. Earnhart C.G., Buckles E.L., Dumler J.S., and Marconi R.T. Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect. Immun. 73 (2005) 7869-7877
30. Terekhova D., Iyer R., Wormser G.P., and Schwartz I. Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J. Bacteriol. 188 (2006) 6124-6134
31. Hanincova K., Liveris D., Sandigursky S., Wormser G.P., and Schwartz I. Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis. Appl. Environ. Microbiol. 74 (2008) 5008-5014
32. Qiu W.G., Bosler E.M., Campbell J.R., Ugine G.D., Wang I.N., Luft B.J., and Dykhuizen D.E. A population genetic study of Borrelia burgdorferi sensu stricto from eastern Long Island, New York, suggested frequency-dependent selection, gene flow and host adaptation. Hereditas 127 (1997) 203-216
33. Wang I.N., Dykhuizen D.E., Qiu W., Dunn J.J., Bosler E.M., and Luft B.J. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 151 (1999) 15-30
34. Qiu W.G., Dykhuizen D.E., Acosta M.S., and Luft B.J. Geographic uniformity of the Lyme disease spirochete (Borrelia burgdorferi) and its shared history with tick vector (Ixodes scapularis) in the Northeastern United States. Genetics 160 (2002) 833-849
35. Earnhart C.G., and Marconi R.T. OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine. Clin. Vaccine Immunol. 14 (2007) 628-634
36. Brisson D., and Dykhuizen D.E. ospC diversity in Borrelia burgdorferi: different hosts are different niches. Genetics 168 (2004) 713-722
37. Theisen M., Borre M., Mathiesen M.J., Mikkelsen B., Lebech A.M., and Hansen K. Evolution of the Borrelia burgdorferi outer surface protein OspC. J. Bacteriol. 177 (1995) 3036-3044
38. Bockenstedt L.K., Hodzic E., Feng S., Bourrel K.W., de Silva A., Montgomery R.R., Fikrig E., Radolf J.D., and Barthold S.W. Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect. Immun. 65 (1997) 4661-4667
39. Gilmore Jr. R.D., Bacon R.M., Carpio A.M., Piesman J., Dolan M.C., and Mbow M.L. Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi. J. Med. Microbiol. 52 (2003) 551-556
40. Lagal V., Postic D., Ruzic-Sabljic E., and Baranton G. Genetic diversity among Borrelia strains determined by single-strand conformation polymorphism analysis of the ospC gene and its association with invasiveness. J. Clin. Microbiol. 41 (2003) 5059-5065
41. Wormser G.P., Brisson D., Liveris D., Hanincova K., Sandigursky S., Nowakowski J., Nadelman R.B., Ludin S., and Schwartz I. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J. Infect. Dis. 198 (2008) 1358-1364
42. Dykhuizen D.E., Brisson D., Sandigursky S., Wormser G.P., Nowakowski J., Nadelman R.B., and Schwartz I. The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am. J. Trop. Med. Hyg. 78 (2008) 806-810
43. Alghaferi M.Y., Anderson J.M., Park J., Auwaerter P.G., Aucott J.N., Norris D.E., and Dumler J.S. Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes. J. Clin. Microbiol. 43 (2005) 1879-1884